Literature DB >> 25842054

Predominance of B haplotype associated KIR genes in Tamil Speaking Dravidians.

Stalinraja Maruthamuthu1, Jayalakshmi Mariakuttikan2.   

Abstract

Killer cell immunoglobulin like receptors (KIRs) are a group of activating (aKIRs) and inhibitory receptors (iKIRs) expressed on subsets of lymphoid cells. Their interaction with HLA class I molecules modulate the innate and adaptive immune response against infections and malignancies. KIR haplotypes varies in gene content and also at allelic level, thereby, distinguishing individuals and populations. Hence, the present study is aimed to determine the KIR gene diversity in Piramalai Kallar (PK) population of South India. The PK population shows diverged KIR gene frequencies and novel haplotypes than other South Indian populations. 52 different KIR gene profiles were identified and 18 of them were new in this population. In phylogenetic analysis the study population is positioned between African and Iranian population in the clade, which supports the South African ancestry of Indian population.
Copyright © 2015 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LD; NK cells; Polymorphism; South Indian; aKIR; iKIR

Mesh:

Substances:

Year:  2015        PMID: 25842054     DOI: 10.1016/j.humimm.2015.03.004

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  2 in total

1.  KIR : HLA association with clinical manifestations of HBV infection in Madurai, south India.

Authors:  Narayanan Kalyanaraman; Lakshmikanthan Thayumanavan; Mariakuttikan Jayalakshmi
Journal:  J Genet       Date:  2016-03       Impact factor: 1.166

Review 2.  Footprint of the COVID-19 Pandemic in India: A Study of Immune Landscape and Other Factors Shielding Mortality.

Authors:  Noura Al-Dayan; Divya Venugopal; Sugapriya Dhanasekaran
Journal:  Anal Cell Pathol (Amst)       Date:  2020-12-24       Impact factor: 2.916

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.